APA

Morshaeuser L., May M., Burger M., Otto W., Hutterer G. C., Pichler M., Klatte T., Wild P., Buser L. & Brookman-May S. (20181024). p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models. : Urologic oncology.

Chicago

Morshaeuser Laura, May Matthias, Burger Maximilian, Otto Wolfgang, Hutterer Georg C, Pichler Martin, Klatte Tobias, Wild Peter, Buser Lorenz and Brookman-May Sabine. 20181024. p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models. : Urologic oncology.

Harvard

Morshaeuser L., May M., Burger M., Otto W., Hutterer G. C., Pichler M., Klatte T., Wild P., Buser L. and Brookman-May S. (20181024). p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models. : Urologic oncology.

MLA

Morshaeuser Laura, May Matthias, Burger Maximilian, Otto Wolfgang, Hutterer Georg C, Pichler Martin, Klatte Tobias, Wild Peter, Buser Lorenz and Brookman-May Sabine. p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models. : Urologic oncology. 20181024.